At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
AG1 - Nutritional Supplement +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of a Novel Nutritional Product on Nutrient Gaps and Gut Health in Active Adults
In Brief
A clinical study evaluating AG1 - Nutritional Supplement and Placebo for Gastrointestinal Microbiome and 2 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This study is a randomized, double-blind, placebo-controlled study of N=20 active men and women. This study to assess the effect of a novel dietary supplement on improving nutrient gaps and the gut microbiome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Microbiome, Nutrition, Healthy, Exercise
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20252026
First PostedJul 2024
Enrollment StartAug 2024
Primary CompletionNov 2024
Study CompletionDec 2024
TodayJul 2026
First PostedJul 26, 2024
Enrollment StartAug 1, 2024
Primary CompletionNov 1, 2024
Study CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.9 years ago
Interventions
AG1 - Nutritional Supplementdietary
A foundational nutritional supplement consisting of vitamins, minerals, probiotics, prebiotics, and whole food ingredients
Placebodietary
Maltodextrin placebo